Scott D. Sandell
Director at Robinhood Markets; 10% owner at IonQ; 10% owner at SpyGlass Pharma. Based in Timonium, Maryland.
- Rank
- 1773rd of 14,644
- Companies held
- 8
- Largest holding
- NET, 83.6% of total
- Latest SEC filing
- Jun 30, 2026
- Listed but not counted
- $3.03B
What the $81.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Cloudflare NET Class A Common Stock | Through Blue Mountain Trust | 174,534 | $303.68 | $53.0M | 65.5% | Form 4, Jun 30, 2026 |
| Cloudflare NET Class A Common Stock | Indirectly (see filing footnote) | 37,000 | $303.68 | $11.2M | 13.9% | Form 4, Jun 30, 2026 |
| Bloom Energy BE Class A Common Stock | Directly | 55,751 | $168.11 | $9.4M | 11.6% | Form 4, Mar 31, 2022 |
| Cloudflare NET Class A Common Stock | Directly | 11,378 | $303.68 | $3.5M | 4.3% | Form 4, Jun 30, 2026 |
| Robinhood Markets HOOD Class A Common Stock | Through Blue Mountain Trust | 27,736 | $68.65 | $1.9M | 2.4% | Form 4, May 12, 2022 |
| Mirum Pharmaceuticals MIRM Common Stock | Indirectly (see filing footnote) | 11,348 | $95.51 | $1.1M | 1.3% | Form 4, Jun 13, 2023 |
| Robinhood Markets HOOD Class A Common Stock | Through Scott Sandell Rising River Trust | 4,396 | $68.65 | $302K | 0.4% | Form 4, May 2, 2022 |
| Coursera COUR Common Stock | Directly Reported jointly by 2 insiders; split evenly | 53,115 | $3.45 | $183K | 0.2% | Form 4, Jun 11, 2026 |
| IonQ IONQ Common Stock | Through Blue Mountain Trust | 7,201 | $22.71 | $164K | 0.2% | Form 4, Nov 16, 2022 |
| Mirum Pharmaceuticals MIRM Common Stock | Through Blue Mountain Trust | 1,455 | $95.51 | $139K | 0.2% | Form 4, Jun 13, 2023 |
| Sagimet Biosciences SGMT Series A Common Stock | Through Blue Mountain Trust | 6,997 | $9.62 | $67K | 0.1% | Form 4, Jan 29, 2024 |
| IonQ IONQ Common Stock | Through Jennifer Sandell Rising River Trust | 1,141 | $22.71 | $26K | 0.0% | Form 4, Nov 16, 2022 |
| IonQ IONQ Common Stock | Through NEA LLC | 1,047 | $22.71 | $24K | 0.0% | Form 4, Nov 16, 2022 |
| Mirum Pharmaceuticals MIRM Common Stock | Through Jennifer Sandell Rising River Trust | 163 | $95.51 | $16K | 0.0% | Form 4, Jun 13, 2023 |
| Ardelyx ARDX Common Stock | Through Scott Sandell Rising River Trust | 47 | $3.06 | $144 | 0.0% | Form 4, Dec 9, 2021 |
Share counts are the amounts Scott D. Sandell reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Scott D. Sandell's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Robinhood Markets HOOD Class A Common Stock | Through NEA 15 GP, LLC Held by a company or fund the insider manages | 21,794,172 | $68.65 | $1.50B | — | Form 4, May 12, 2022 |
| IonQ IONQ Common Stock | Through NEA 15 GP, LLC Held by a company or fund the insider manages | 14,614,829 | $22.71 | $332M | — | Form 4, Nov 16, 2022 |
| Mirum Pharmaceuticals MIRM Common Stock | Through NEA 16 GP, LLC Held by a company or fund the insider manages | 2,186,243 | $95.51 | $209M | — | Form 4, Jun 13, 2023 |
| MBX Biosciences MBX Common Stock | Through NEA 17 GP, LLC Held by a company or fund the insider manages | 3,614,486 | $53.41 | $193M | — | Form 4, Sep 16, 2024 |
| SpyGlass Pharma SGP Common Stock | Through NEA 17 GP, LLC Held by a company or fund the insider manages | 6,035,038 | $30.78 | $186M | — | Form 4, Feb 9, 2026 |
| Trevi Therapeutics TRVI Common Stock | Through NEA 16 GP, LLC Held by a company or fund the insider manages | 12,273,280 | $13.72 | $168M | — | Form 5, Apr 17, 2025 |
| Robinhood Markets HOOD Class A Common Stock | Through NEA 17 GP, LLC Held by a company or fund the insider manages | 2,028,736 | $68.65 | $139M | — | Form 4, May 12, 2022 |
| Savara SVRA Common Stock | Through NEA 17 GP, LLC Held by a company or fund the insider manages | 24,471,264 | $5.21 | $127M | — | Form 4, Jul 17, 2023 |
| SpyGlass Pharma SGP Common Stock | Through NEA 16 GP, LLC Held by a company or fund the insider manages | 1,357,263 | $30.78 | $41.8M | — | Form 4, Feb 9, 2026 |
| Coursera COUR Common Stock | Through NEA 13 GP, LLC Held by a company or fund the insider manages | 10,661,886 | $3.45 | $36.8M | — | Form 4, Jun 11, 2026 |
| Sagimet Biosciences SGMT Series A Common Stock | Through NEA Partners 13, L.P. Held by a company or fund the insider manages | 3,000,275 | $9.62 | $28.9M | — | Form 4, Jan 29, 2024 |
| Ardelyx ARDX Common Stock | Through NEA 12 GP, LLC Held by a company or fund the insider manages | 6,207,480 | $3.06 | $19.0M | — | Form 4, Dec 15, 2021 |
| Korro Bio KRRO Common Stock | Through NEA 17 GP, LLC Held by a company or fund the insider manages | 1,297,893 | $12.19 | $15.8M | — | Form 4, Mar 10, 2026 |
| Trevi Therapeutics TRVI Common Stock | Through NEA 18 VGE GP, LLC Held by a company or fund the insider manages | 948,948 | $13.72 | $13.0M | — | Form 5, Dec 31, 2025 |
| Coursera COUR Common Stock | Through NEA 17 GP, LLC Held by a company or fund the insider manages | 2,205,883 | $3.45 | $7.6M | — | Form 4, Jun 11, 2026 |
| Ardelyx ARDX Common Stock | Through NEA 15 GP, LLC Held by a company or fund the insider manages | 2,285,682 | $3.06 | $7.0M | — | Form 4, Dec 14, 2021 |
| Ardelyx ARDX Common Stock | Through NEA Partners 15-OF, L.P. Held by a company or fund the insider manages | 2,258,850 | $3.06 | $6.9M | — | Form 4, Dec 15, 2021 |
| Crescent Biopharma CBIO Common Stock | Through NEA Partners 10, Limited Partnership Held by a company or fund the insider manages | 27,303 split-adjusted | $12.91 | $352K | — | Form 4, Jan 26, 2023 |
| Crescent Biopharma CBIO Common Stock | Through NEA Partners 13, L.P. Held by a company or fund the insider manages | 22,372 split-adjusted | $12.91 | $289K | — | Form 4, Jan 26, 2023 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1770 | Douglas M. Shipley 10% owner, Legacy Housing. Bedford, TX | $81.0M |
| 1771 | Mario Schlosser Director, Oscar Health. Pittsburgh, PA | $81.0M |
| 1772 | William R. Shepard Director, CME Group. Chicago, IL | $81.0M |
| 1773 | Scott D. Sandell Director, Robinhood Markets. Timonium, MD | $81.0M |
| 1774 | Elinor Mertz Chief Financial Officer, Airbnb. San Francisco, CA | $80.9M |
| 1775 | William D. Jenkins Jr. President, Palo Alto Networks. Santa Clara, CA | $80.9M |
| 1776 | Michael G. O'Grady Chairman and CEO, Northern Trust. Chicago, IL | $80.9M |
Other Robinhood Markets insiders
All HOOD insiders- Vladimir Tenev$3.26BChief Executive Officer. #100 overall
- Baiju Bhatt$3.21BDirector. #102 overall
- Meyer Malka$273MDirector. #721 overall
- Gretchen Howard$59.8MChief Operating Officer. #2205 overall
- Daniel M. Gallagher, Jr$33.6MChief Legal Officer. #3441 overall
- Jason Warnick$27.6MInsider. #4034 overall
Questions
How much stock does Scott D. Sandell own?
Scott D. Sandell holds $80,974,387 in listed stock based on SEC filings and current prices, mostly Cloudflare (NET). That ranks 1773rd on the Stock Rich List.
Is this Scott D. Sandell's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Scott D. Sandell last buy or sell stock?
The most recent open-market trade on file is a purchase of 207,100 KRRO shares on Mar 10, 2026 at $11.11.